|Bid||13.75 x 2200|
|Ask||13.85 x 1300|
|Day's Range||13.10 - 14.27|
|52 Week Range||9.66 - 27.18|
|Beta (5Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Earnings Date||Mar 30, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
STAMFORD, Conn., Jun 17, 2021--Sema4 appoints Andrew Kasarskis, PhD, to the newly established role of Chief Data Officer (CDO).
The filing of the amended proxy statement marks the next step in the formal Securities and Exchange Commission (SEC) review process.
AdventHealth is leveraging Sema4’s health intelligence platform to enable a range of clinical and research initiatives